358 related articles for article (PubMed ID: 37919901)
1. mRNA vaccines and their delivery strategies: A journey from infectious diseases to cancer.
Malla R; Srilatha M; Farran B; Nagaraju GP
Mol Ther; 2024 Jan; 32(1):13-31. PubMed ID: 37919901
[TBL] [Abstract][Full Text] [Related]
2. Recent progress in mRNA cancer vaccines.
Yao R; Xie C; Xia X
Hum Vaccin Immunother; 2024 Dec; 20(1):2307187. PubMed ID: 38282471
[TBL] [Abstract][Full Text] [Related]
3. Emerging advances in delivery systems for mRNA cancer vaccines.
Jiang Z; Xu Y; Du G; Sun X
J Control Release; 2024 Jun; 370():287-301. PubMed ID: 38679162
[TBL] [Abstract][Full Text] [Related]
4. Clinical and immunological effects of mRNA vaccines in malignant diseases.
Heine A; Juranek S; Brossart P
Mol Cancer; 2021 Mar; 20(1):52. PubMed ID: 33722265
[TBL] [Abstract][Full Text] [Related]
5. The Current Landscape of mRNA Vaccines Against Viruses and Cancer-A Mini Review.
Ladak RJ; He AJ; Huang YH; Ding Y
Front Immunol; 2022; 13():885371. PubMed ID: 35603213
[TBL] [Abstract][Full Text] [Related]
6. Formulation and Delivery Technologies for mRNA Vaccines.
Zeng C; Zhang C; Walker PG; Dong Y
Curr Top Microbiol Immunol; 2022; 440():71-110. PubMed ID: 32483657
[TBL] [Abstract][Full Text] [Related]
7. The clinical progress and challenges of mRNA vaccines.
Yu MZ; Wang NN; Zhu JQ; Lin YX
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1894. PubMed ID: 37096256
[TBL] [Abstract][Full Text] [Related]
8. Advanced nanoscale delivery systems for mRNA-based vaccines.
Mobasher M; Ansari R; Castejon AM; Barar J; Omidi Y
Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130558. PubMed ID: 38185238
[TBL] [Abstract][Full Text] [Related]
9. The Changing Landscape of Therapeutic Cancer Vaccines-Novel Platforms and Neoantigen Identification.
Jou J; Harrington KJ; Zocca MB; Ehrnrooth E; Cohen EEW
Clin Cancer Res; 2021 Feb; 27(3):689-703. PubMed ID: 33122346
[TBL] [Abstract][Full Text] [Related]
10. Nonlysosomal Route of mRNA Delivery and Combining with Epigenetic Regulation Optimized Antitumor Immunoprophylactic Efficacy.
Liu Y; Liu X; Huang J; Shi Y; Luo Z; Zhang J; Guo X; Jiang M; Li X; Yin H; Qin B; Guan G; Luo L; Zhou Y; You J
Adv Healthc Mater; 2023 Feb; 12(4):e2202460. PubMed ID: 36366890
[TBL] [Abstract][Full Text] [Related]
11. mRNA vaccines for cancer immunotherapy.
Vishweshwaraiah YL; Dokholyan NV
Front Immunol; 2022; 13():1029069. PubMed ID: 36591226
[TBL] [Abstract][Full Text] [Related]
12. mRNA Cancer Vaccines.
Fiedler K; Lazzaro S; Lutz J; Rauch S; Heidenreich R
Recent Results Cancer Res; 2016; 209():61-85. PubMed ID: 28101688
[TBL] [Abstract][Full Text] [Related]
13. Emergence of mRNA vaccines in the management of cancer.
Mohamad Razif MI; Nizar N; Zainal Abidin NH; Muhammad Ali SN; Wan Zarimi WNN; Khotib J; Susanti D; Mohd Jailani MT; Taher M
Expert Rev Vaccines; 2023; 22(1):629-642. PubMed ID: 37401128
[TBL] [Abstract][Full Text] [Related]
14. mRNA delivery technologies: Toward clinical translation.
Gómez-Aguado I; Rodríguez-Castejón J; Beraza-Millor M; Rodríguez-Gascón A; Del Pozo-Rodríguez A; Solinís MÁ
Int Rev Cell Mol Biol; 2022; 372():207-293. PubMed ID: 36064265
[TBL] [Abstract][Full Text] [Related]
15. Transcutaneous delivery of DNA/mRNA for cancer therapeutic vaccination.
Sun X; Zeng L; Huang Y
J Gene Med; 2019 Jul; 21(7):e3089. PubMed ID: 30958606
[TBL] [Abstract][Full Text] [Related]
16. RNA-Based Vaccines in Cancer Immunotherapy.
McNamara MA; Nair SK; Holl EK
J Immunol Res; 2015; 2015():794528. PubMed ID: 26665011
[TBL] [Abstract][Full Text] [Related]
17. Polymer-Based mRNA Delivery Strategies for Advanced Therapies.
Yang W; Mixich L; Boonstra E; Cabral H
Adv Healthc Mater; 2023 Jun; 12(15):e2202688. PubMed ID: 36785927
[TBL] [Abstract][Full Text] [Related]
18. Challenges and advances towards the rational design of mRNA vaccines.
Pollard C; De Koker S; Saelens X; Vanham G; Grooten J
Trends Mol Med; 2013 Dec; 19(12):705-13. PubMed ID: 24138818
[TBL] [Abstract][Full Text] [Related]
19. mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy.
Deng Z; Tian Y; Song J; An G; Yang P
Front Immunol; 2022; 13():887125. PubMed ID: 35720301
[TBL] [Abstract][Full Text] [Related]
20. Advances in mRNA vaccines.
Li M; Wang Z; Xie C; Xia X
Int Rev Cell Mol Biol; 2022; 372():295-316. PubMed ID: 36064266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
